Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Servier
Biotech
Molecular glue biotech f5 Therapeutics closes down
Molecular glue-focused biotech f5 Therapeutics has failed to stick around for the long haul, shuttering after six years.
Gabrielle Masson
Mar 10, 2026 1:10pm
Fierce Pharma
Servier rounds out rare cancer offerings with $2.5B Day One buy
Mar 6, 2026 10:14am
Biotech money moves: 3 new venture funds raise nearly $1B
Jan 9, 2026 1:20pm
Insilico pens potential $888M cancer R&D pact with Servier
Jan 4, 2026 7:30pm
Nuvation cancels plans to directly challenge Servier's Voranigo
Nov 4, 2025 7:10am
Servier supercharges neuro pipeline with $450M deal
Sep 8, 2025 2:30am
